No Data
Denali Therapeutics(DNLI.US) Director Sells US$34,132.86 in Common Stock
$Denali Therapeutics(DNLI.US)$ Director SATO VICKI L sold 1,674 shares of common stock on May 15, 2024 at an average price of $20.39 for a total value of $34,132.86.Source: Announcement What is statem
Stifel Nicolaus Sticks to Their Hold Rating for Denali Therapeutics (DNLI)
Cantor Picks 14 Undervalued Biotech Stocks Worth a Second Look
Analysts Have Just Cut Their Denali Therapeutics Inc. (NASDAQ:DNLI) Revenue Estimates By 29%
Market forces rained on the parade of Denali Therapeutics Inc. (NASDAQ:DNLI) shareholders today, when the analysts downgraded their forecasts for this year.
The Consensus EPS Estimates For Denali Therapeutics Inc. (NASDAQ:DNLI) Just Fell Dramatically
Optimistic Outlook for Denali Therapeutics: Buy Rating Affirmed Amidst Positive ERT Developments and Strong Pipeline Progress